Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Veber

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry|September 1, 1994
Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformationP D Williams, R G Ball, B V Clineschmidt, et al.
Thrombosis and Haemostasis|October 1, 1995
Inhibition of thrombin by peptides containing Lysyl-alpha-keto carbonyl derivativesS D Lewis, A S Ng, E A Lyle, et al.
Journal of Medicinal Chemistry|July 1, 1987
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
Journal of Medicinal Chemistry|January 1, 1990
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadomM G Bock, R M DiPardo, B E Evans, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
In vitro pharmacological profile of a novel structural class of oxytocin antagonistsD J Pettibone, B V Clineschmidt, E V Lis, et al.
Journal of Medicinal Chemistry|October 16, 1992
Orally active, nonpeptide oxytocin antagonistsB E Evans, J L Leighton, K E Rittle, et al.
Journal of Medicinal Chemistry|December 1, 1988
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
European Journal of Pharmacology|April 24, 1991
Bradykinin agonist activity of a novel, potent oxytocin antagonistD J Pettibone, B V Clineschmidt, E V Lis, et al.
Biochemical and Biophysical Research Communications|October 14, 1988
HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteinsP L Darke, R F Nutt, S F Brady, et al.
Journal of Medicinal Chemistry|October 1, 1986
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubilityM G Bock, R M DiPardo, K E Rittle, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry|September 1, 1994
Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformationP D Williams, R G Ball, B V Clineschmidt, et al.
Thrombosis and Haemostasis|October 1, 1995
Inhibition of thrombin by peptides containing Lysyl-alpha-keto carbonyl derivativesS D Lewis, A S Ng, E A Lyle, et al.
Journal of Medicinal Chemistry|July 1, 1987
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
Journal of Medicinal Chemistry|January 1, 1990
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadomM G Bock, R M DiPardo, B E Evans, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
In vitro pharmacological profile of a novel structural class of oxytocin antagonistsD J Pettibone, B V Clineschmidt, E V Lis, et al.
Journal of Medicinal Chemistry|October 16, 1992
Orally active, nonpeptide oxytocin antagonistsB E Evans, J L Leighton, K E Rittle, et al.
Journal of Medicinal Chemistry|December 1, 1988
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
European Journal of Pharmacology|April 24, 1991
Bradykinin agonist activity of a novel, potent oxytocin antagonistD J Pettibone, B V Clineschmidt, E V Lis, et al.
Biochemical and Biophysical Research Communications|October 14, 1988
HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteinsP L Darke, R F Nutt, S F Brady, et al.
Journal of Medicinal Chemistry|October 1, 1986
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubilityM G Bock, R M DiPardo, K E Rittle, et al.
Pageof 10